1
Tarran Jones
Mary M Bendig, Olivier J Leger, Jose Saldanha, S Tarran Jones, Ted A Yednock: Humanized antibodies against leukocyte adhesion molecule VLA-4. Athena Neurosciences, Townsend & Townsend & Crew, November 24, 1998: US05840299 (86 worldwide citation)

The invention provides humanized immunoglobulins that specifically bind to the VLA-4 ligand, and methods of treatment using the same. The methods are particularly useful for treatment of multiple sclerosis.


2
Tarran Jones
Bendig Mary M, Leger Olivier J, Saldanha Jose, Jones Tarran S, Yednock Theodore A: Humanized antibodies against leukocyte adhesion molecule vla-4. Elan Pharm, March 7, 2007: EP1759709-A1

The invention provides humanized immunoglobulins that specifically bind to the VLA-4 ligand, and methods of treatment using the same. The methods are particularly useful for the treatment of multiple sclerosis.


3
Tarran Jones
Bendig Mary M, Leger Olivier J, Saldanha Jose, Jones Tarran S: Humanized antibodies against leukocyte adhesion molecule vla-4. Athena Neurosciences, November 5, 1997: EP0804237-A1

The invention provides humanized immunoglobulins that specifically bind to the VLA-4 ligand, and methods of treatment using the same. The methods are particularly useful for treatment of multiple sclerosis.


4
Mary M Bendig, Olivier J Leger, Jose Saldanha: Humanized antibodies against leukocyte adhesion molecule vla-4. Athena Neurosciences, WANG DAZUO, January 15, 1997: CN95191354

The invention provides humanized immunoglobulins that specifically bind to the VLA-4 ligand, and methods of treatment using the same. The methods are particularly useful for treatment of multiple sclerosis.


5
Tarran Jones
Bendig Mary M, Leger Olivier J, Saldanha Jose, Jones S Tarran, Yednock Ted A: Anticorps humanises diriges contre la molecule dadhesion leucocytaire vla-4, Humanized antibodies against leukocyte adhesion molecule vla-4. Athena Neurosciences, Elan Pharmaceuticals, GOWLING LAFLEUR HENDERSON, July 27, 1995: CA2182013

The invention provides humanized immunoglobulins that specifically bind to the V LA-4 ligand, and methods of treatment using the same. The methods are particularly useful for treatment of multiple sclerosis.


6
Tarran Jones
Bendig Mary M, Leger Olivier J, Saldanha Jose, Jones Tarran S: Humanized antibodies against leukocyte adhesion molecule vla-4. Athena Neurosciences, Bendig Mary M, Leger Olivier J, Saldanha Jose, Jones Tarran S, LIEBESCHUETZ Joe, July 27, 1995: WO/1995/019790

The invention provides humanized immunoglobulins that specifically bind to the VLA-4 ligand, and methods of treatment using the same. The methods are particularly useful for treatment of multiple sclerosis.



Click the thumbnails below to visualize the patent trend.